Scout | HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)

This opportunity is no longer accepting applications.

grant

HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)

This grant opportunity is designed to fund the improvement and development of therapies that are safe, effective, and non-addictive for treating pain. It aims to speed up the advancement of promising drug candidates, both small molecule and biologic, towards clinical trials. To be eligible, applicants must have a promising drug candidate, a strong scientific basis for their approach, and suita…

Source

Agency: National Institutes of Health

Sub-agency: National Institute of Neurological Disorders and Stroke

Dates

Opportunity Released: October 31, 2023

Open for Submission: October 31, 2023

Submission Deadline: January 7, 2027

Application Window Closes: January 7, 2027

Keywords

Preclinical optimization

small molecule therapeutics

biologic therapeutics

pain treatment

non-addictive therapeutics

clinical trials

IND-enabling studies

biological rationale

Investigational New Drug

NIH cooperative agreement.

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers